A trial tested the efficacy of corticosteroids in reducing interstitial fibrosis after kidney transplantation in low-risk patients.

Following priority review, the U.S. Food and Drug Administration approved Bayer's Kerendia (finerenone) for the treatment of ...

The primary endpoint was functional immune tolerance, defined as off all immunosuppressive drugs 24 months after ...

A recent study led by Paul DeCaen, Ph.D., associate professor of Pharmacology, has identified novel molecular mechanisms by ...

A new research paper was published in Volume 16 of Oncotarget on June 25, 2025, titled "Hypoxia induced lipid droplet ...